| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $97.2M | -2.0% | +4.8% |
| SG&A Expense | $16.7M | +0.7% | +29.7% |
| Operating Income | -$113.9M | +1.6% | -7.8% |
| Interest Expense | $2.9M | +2989.4% | — |
| Net Income | -$108.0M | +2.5% | -11.2% |
| EPS (Basic) | -$0.76 | +21.6% | +20.8% |
| EPS (Diluted) | -$0.76 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $573.6M | +18.3% | +7.8% |
| Current Assets | $806.3M | +15.5% | +9.5% |
| Total Assets | $867.1M | +18.9% | +12.8% |
| Current Liabilities | $59.8M | +44.3% | +38.3% |
| Long-term Debt | $99.1M | +0.3% | — |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$291.4M | — | — |
| Capital Expenditures | $1.4M | — | — |
| Investing Cash Flow | -$29.7M | — | — |
| Financing Cash Flow | $459.3M | — | — |
| Free Cash Flow | -$292.8M | — | — |
| +21.6% |
| +20.8% |
| $175.3M |
| +11.3% |
| +176.9% |
| Stockholders' Equity | $691.8M | +21.1% | -1.9% |